SARS-CoV-2 antigen testing: weighing the false positives against the costs of failing to control transmission

Research output: Contribution to journal › Article (Academic Journal) › peer-review

11 Citations (Scopus)

Original language	English
Pages (from-to)	685-687
Number of pages	3
Journal	The Lancet Respiratory Medicine
Volume	9
Issue number	7
Early online date	14 Jun 2021
DOIs	https://doi.org/10.1016/s2213-2600(21)00234-4
Publication status	Published - 1 Jul 2021

Access to Document

@article{fa457b5319424653a0d0fbbecfbd1b6d,

title = "SARS-CoV-2 antigen testing: weighing the false positives against the costs of failing to control transmission",

author = "Helena Stage",

year = "2021",

month = jul,

day = "1",

doi = "10.1016/s2213-2600(21)00234-4",

language = "English",

volume = "9",

pages = "685--687",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",

publisher = "Elsevier Limited",

number = "7",

}

TY - JOUR

T1 - SARS-CoV-2 antigen testing: weighing the false positives against the costs of failing to control transmission

AU - Stage, Helena

PY - 2021/7/1

Y1 - 2021/7/1

U2 - 10.1016/s2213-2600(21)00234-4

DO - 10.1016/s2213-2600(21)00234-4

M3 - Article (Academic Journal)

SN - 2213-2600

VL - 9

SP - 685

EP - 687

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

IS - 7

ER -